ClinicalTrials.Veeva

Menu
R

Renal Medicine Associates | Albuquerque, NM

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Semaglutide
VX-147
warfarin
Tenapanor
apixaban
PA101B
nalbuphine HCl
Phosphate
Aprocitentan
PF-04634817

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 13 total trials

Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney Disease (AMPLITUDE)

The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants...

Enrolling
Proteinuric Kidney Disease
Drug: Placebo
Drug: VX-147

This study will look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with cardiovascular...

Enrolling
Cardiovascular Disease
Drug: Semaglutide
Drug: Cagrilintide

Trial sponsors

Novo Nordisk logo
T
Ardelyx logo
Bayer logo
Idorsia Pharmaceuticals logo
P
Pfizer logo
Sandoz logo
Shionogi logo
Vertex Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems